Compare Diaceutics Plc with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0.95%
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.06
3
Poor long term growth as Operating profit has grown by an annual rate 6.03% of over the last 5 years
4
Positive results in Dec 25
5
With ROE of 0.24%, it has a very attractive valuation with a 3.04 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.5%
0%
12.5%
6 Months
31.33%
0%
31.33%
1 Year
19.53%
0%
19.53%
2 Years
75.86%
0%
75.86%
3 Years
48.54%
0%
48.54%
4 Years
23.39%
0%
23.39%
5 Years
2.0%
0%
2.0%
Diaceutics Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.79%
EBIT Growth (5y)
6.03%
EBIT to Interest (avg)
-0.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.60
Tax Ratio
14.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.74%
ROE (avg)
0.95%
Valuation key factors
Factor
Value
P/E Ratio
123
Industry P/E
Price to Book Value
3.04
EV to EBIT
-116.06
EV to EBITDA
20.73
EV to Capital Employed
3.47
EV to Sales
3.02
PEG Ratio
1.16
Dividend Yield
NA
ROCE (Latest)
-0.63%
ROE (Latest)
0.24%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
32.20
23.70
35.86%
Operating Profit (PBDIT) excl Other Income
2.30
2.10
9.52%
Interest
0.10
0.10
Exceptional Items
-0.50
0.00
Consolidate Net Profit
-1.70
-1.70
Operating Profit Margin (Excl OI)
-71.40%
-114.70%
4.33%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 35.86% vs 21.54% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 0.00% vs -342.86% in Dec 2023
About Diaceutics Plc 
Diaceutics Plc
Pharmaceuticals & Biotechnology
Diaceutics PLC is a United Kingdom-based data analytics and implementation services company which services the global pharmaceutical industry. The Company offers end to end services that encompasses from understanding the diagnostic landscape to test implementation into treatment pathways to enable better treatment decisions for patients. The Company’s data analytics and implementation services, including Landscape, Tracking, and Primary Market Research, leverages the diagnostic testing information to provide data-driven insights to drive seamless integration of diagnostic tests into treatment pathways. Its implementation services include Planning, Commercialization and Reimbursement Landscapes, to build the strategies and implement the tactics that drives optimal test utilization, ensuring that patients are getting the right treatment.
Company Coordinates 
Company Details
727 Antrim Road , BELFAST NIR : BT2 8FE
Registrar Details






